TROG Cancer Research is Australia and New Zealand's specialist clinical research group for cancers that can be treated with radiotherapy. TROG is a cooperative multi-disciplinary organisation dedicated to the control of a wide range of cancers through quality multi-centre research.

 

TROG provides the infrastructure and governance for national and international collaborations to help ensure the development of more effective treatments for cancer. Currently over 300 clinicians and other researchers and over 11,000 patients have contributed to the TROG research program.

 

Through these collaborative efforts, involving more than 60 cancer treatment centres across Australia and New Zealand, as well as contributing centres internationally, TROG has launched over 50 cancer research trials and achieved significant improvements in patient care and outcomes.

 

TROG conducts world-class research involving radiotherapy to improve outcomes and quality of life for people affected by cancer. With collaboration and innovative technologies TROG will explore advances that influence clinical practice.  

 

• COLLABORATION: We will work with key stakeholders, organisations and community groups who share our aim of defeating cancer.
• QUALITY: Our research is guided by innovation, best practice, rigour and accuracy.
• CARE: We provide the utmost care and consideration for patients and families, as well as members of our own team and all those with whom we come into contact during the course of our work.

The TROG 2012 Annual Research Report is now available.

 

        Late breaking call will be between 24 July to 7 August 2013, please contact davi.kaur@ecco-org.eu if you

        have any late breaking data to submit.

        The advance programme can be viewed online at www.ecco-org.eu

 

        The AGITG ASM is being held at the Sofitel Melbourne in conjunction with the Australian Gastroinstestinal

        Week at Melbourne Convention Center from 8 -10 October 2013.

        Poster and New Concepts submissions close 26 August 2013.

        To register or to view the advance program please go to www.agitg.org.au 

  

        Please see the Global Controversies and Advances in Skin Cancer flyer for more information.

        Abstracts submissions close 07 June 2013.

        To register your interest and to view the preliminary program please go to www.gc-sc.org

 

         Twin Waters Resort, Sunshine Coast, QLD

         1st-4th April, 2014

         Convenor: Bryan Burmeister

         For more information visit our Meetings & Events page.

 

There has been a recent decision by the Cancer Institute NSW to transition its Clincal Research Ethics Committee to local ethics operations. Over the next 6-8 months the Cancer Institute NSW will facilitate transition arrangements for current projects overseen by the committee. They will contact chief investigators with open studies regarding arrangements for the ongoing ethical oversight of their projects. Until this transition trials will continue to have current ethical approval. Investigators will receive correspondence about the transition arrangements over the next month.